MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neurovascular and immune determinants of selective vulnerability of dopaminergic neurons in Parkinson’s Disease

T. Balzano, N. Lopez Gonzalez-Del-Rey, N. Esteban-Garcia, A. Reinares-Sebastian, I. Trigo-Damas, JA. Pineda-Pardo, C. Cavada, JA. Obeso, J. Blesa (Mostoles, Spain)

Meeting: 2022 International Congress

Abstract Number: 1540

Keywords: Substantia nigra pars compacta(SNpc)

Category: Parkinson's Disease: Pathophysiology

Objective: We aimed to investigate the contribution of glial cells activation and immune cells infiltration in the selective vulnerability of dopaminergic neurons within the midbrain in a non-human primate model of Parkinson’s Disease (PD). Structural and functional alterations of the blood-brain barrier (BBB) within specific regions of the midbrain have been also evaluated.

Background: Nigrosome, a region identified by poor neuropil calbindin-D28K (CB) immunostaining within the substantia nigra pars compacta (SNpc), contains the largest proportion of dopaminergic neurons affected in PD. However, the factors determining why these neurons are selectively vulnerable while others resist the degenerative process in PD are still poorly understood.

Method: Parkinsonism was induced by systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) using a low dose regimen (0.5 mg/kg every 2 weeks) to obtain partial, slow and progressive degeneration of the dopaminergic system in non-human primates. Based on immunostaining for CB, the dopaminergic midbrain region was subdivided in nigrosome (CB-poor zone) and matrix (CB-rich zones). Adjacent serial sections were then immunostained with markers for glial cells (IBA1 and GFAP), T and B lymphocytes (CD4 and CD20) and brain microvasculature (CD31, GLUT1, ZO-1) to evaluate the role of neuroinflammation and vasculature in the selective vulnerability of dopaminergic neurons within the nigrosome.

Results: MPTP monkeys showed a massive glial activation in the whole midbrain, but no major differences were observed comparing nigrosome and matrix regions. Remarkably, nigrosome region is normally much more vascularized in comparison with the rest of dopaminergic midbrain. This probably makes this region more susceptible to immune cells infiltration under pathological conditions as observed in the nigrosome but not in the matrix of parkinsonian monkeys.

Conclusion: These data suggest that the higher vascular density within the nigrosome may represent the main route of entry of immune cells in the dopaminergic midbrain. The increased infiltration of T and B cells in the nigrosome (but not in the matrix) could contribute to the selective vulnerability of dopaminergic neurons in PD.

To cite this abstract in AMA style:

T. Balzano, N. Lopez Gonzalez-Del-Rey, N. Esteban-Garcia, A. Reinares-Sebastian, I. Trigo-Damas, JA. Pineda-Pardo, C. Cavada, JA. Obeso, J. Blesa. Neurovascular and immune determinants of selective vulnerability of dopaminergic neurons in Parkinson’s Disease [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/neurovascular-and-immune-determinants-of-selective-vulnerability-of-dopaminergic-neurons-in-parkinsons-disease/. Accessed July 11, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neurovascular-and-immune-determinants-of-selective-vulnerability-of-dopaminergic-neurons-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley